AXXE a pharmaceutical company, engages in the marketing and distribution of various pharmaceutical products and diagnostic medical devices in Canada and internationally.
AXXE distributes dermatological, therapeutic nutritional, pain management, and diagnostic products.
AXXE’s principal product line includes Britical, Gravergol, Lactrase, Somnol, Triferexx, Urasal, Axspaz, Vivol, Hydraxx, Kemsol, Soropon, Amersol, Bactalase, Monurol, and Zynol, as well as skin care products.
AXXE distributes its products through physicians, hospitals, government and defense institutions, and pharmacies. The company was founded in 1997 and is headquartered in Markham, Canada.
Exploding Opportunity for Pain Management Companies ($60 Billion Next Year)
The highly fragmented pain-management market poses an opportunity for new classes of drugs targeting neuropathic pain as well as for generics as standard therapies come off patent.
Because current therapies are often less than effective or have undesirable side effects, there also are emerging opportunities using genomics to match patients to pain medications.
Pain management today is dominated by Pfizer, Eli Lilly, Purdue Pharma, Endo Pharmaceuticals, Novartis, Johnson & Johnson, and Grünenthal. “Among these, Purdue Pharma, Endo, and Grünenthal specialize in pain,” points out Karen Holmes, senior market analyst and author of the recent Espicom Business Intelligence report, Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic Drug Development.
“Pfizer is by far the biggest player, consolidating its position with the acquisition of King Pharmaceuticals and Icagen. Including line extensions, Pfizer has at least 10 compounds in clinical development for pain indications.”
Whether those leaders will manage to maintain their positions depends upon how they manage their patent expirations as well as new drug development. “You have to be paranoid about the competition. The science isn’t stopping,” says John Steuart, managing partner, Claremont Creek Ventures. “Thousands of biotechs and tens of thousands of academic labs are working to develop new therapies all the time.” Pain management, he admits, is a mature market, so new therapies must be proven more efficacious or less toxic than existing medications.
Booming Market
Market projections vary, but Espicom estimated the global pain-management market at $46.4 billion at the close of 2011. The U.S. market accounts for 48% of that. Another market analyst, Global Industry Analysts (GIA), one year ago predicted the global pain-management market would reach $60 billion by 2015.
That predicted growth is based upon an aging global population, increasing number of surgeries, lifestyle changes, and a rising incidence of cancer. Some 1.5 billion of the world’s 7 billion people—21%—currently suffer from pain.
That includes approximately 30% of all cancer patients and 60% of late-stage cancer patients.
The largest markets for pain-management medications currently are the U.S. and Europe. As with many pharmaceuticals, however, the fastest-growing markets are expected to be in Asia and Latin America, according to the GIA analysis, Pain Management: A Global Strategic Business Report. It anticipates a 9% compounded annual growth rate for pain-management therapies in Latin America between 2007 and 2015.
Recent AXXE News Developments
Axxess Pharma Is Pleased to Announce That Amazon.com Has Placed Its Initial Order for the Company's TapouT Sports Nutrition Line
TORONTO, ON--(Marketwired - Feb 24, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce that its TapouT pain relief and vitamins & supplements, including its new Extreme Muscle Growth and Recovery line, will soon be available for purchase directly from Amazon.com, the largest worldwide online retailer.
The addition of TapouT's pain relief, vitamin and supplement lines to Amazon.com will allow the company to provide a broader range of products to consumers all over the world. Amazon will also soon carry TapouT's Muscle Recovery, a topical muscle pain and fatigue reducer, reusable hot and cold packs and single-use instant cold packs.
Dr. Daniel Bagi, President of Axxess Pharma, stated: "We are absolutely thrilled with this initial purchase order from Amazon.com. Hand in hand with this major milestone for AXXESS and AllStar we will be channeling marketing efforts to support and grow the demand for our high-quality nutritional supplements and muscle recovery products."
Amazon.com strives to be Earth's most customer-centric company where people can find and discover virtually anything they want to buy online. By giving customers more of what they want -- low prices, vast selection, and convenience -- Amazon.com continues to grow and evolve as a world-class e-commerce platform.
TapouT Muscle Recovery products will be available for purchase on Amazon.com in the next month.
Axxess Pharma Inc. Announces Launch of US TapouT Sales: Initial PO Through NPI, Nutritional Products International, a Leading Brand Management Company
TORONTO, ON--(Marketwired - Feb 18, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary AllStar Health Brands Inc., is pleased to announce that its TapouT Pain Relief and Vitamins & Supplements, including its new Extreme Muscle Growth and Recovery line is now available for purchase on www.revnutrition.com, a leading online sports nutrition and supplement retailer.
Daniel Bagi, President of Axxess stated, "This initial PO we believe is a sign of things to come, and we are very confident Mitch and his team at NPI will help us grow the TapouT brand of Pain relief and Supplements both in the US and international markets."
The TapouT Sports Nutrition line includes several different all-natural sports nutrition products. The company also offers a topical muscle recovery spray, which helps eliminate pain, reduces fatigue and increases performance that is available in both spray and towellet forms. TapouT Muscle Recovery allows you to train harder and recover faster without the dangers of traditional painkillers. In addition to their muscle recovery products, they also have a reusable hot and cold pack, along with single-use instant cold packs, that can be used at anytime, anywhere.
Nutritional Products International (NPI), who handles the United States distribution for the company is excited to begin branching out the full TapouT Sports Nutrition line. NPI has the ability to reach thousands of retail outlets across the United States. The company also exports products to all seven continents.
"With TapouT Sports Nutrition products, we see nothing that can stop these products from becoming an even bigger household name than they already are," says NPI CEO, Mitch Gould. "We fully believe this line will be a huge success. If these products are good enough for some of the hardest training athletes in the world, then they will do wonders for everyone who uses them."
RevNutrition.com offers a broad range of high-quality, affordable wellness products to consumers around the world. The site offers consumers a wide range to choose from many of the most trusted names in the nutritional products industry.
To purchase TapouT products, please visit: http://www.tapout.com/
AXXE at its current price level is perfectly positioned for a strong move to the upside!
